Liquidity, Going Concern and Management Plans (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended	12 Months Ended
	Jan. 06, 2025	Jan. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Compensating Balances [Line Items]
Cash, cash equivalents, restricted cash, and restricted cash equivalents			$ 167,600
Working capital deficit			241,300
Accumulated deficit			2,017,796	$ 1,845,542
Net loss from continuing operations			177,778	$ 293,102	$ 425,045
Subsequent Event | Settled Litigation
Compensating Balances [Line Items]
Litigation settlement payment	$ 220,000	$ 220,000
Convertible Debt
Compensating Balances [Line Items]
Accrued interest			27,100
2026 Notes | Convertible Debt
Compensating Balances [Line Items]
Debt instrument, repurchased face amount			46,900
Sales Agreement
Compensating Balances [Line Items]
Proceeds from issuance of common stock			43,300
Deduction of commission and expenses			$ 1,000
Issuance of common stock for cash (in shares)			33,218,851
Weighted average gross sale price per share			$ 1.33